Kranzler Jay D

Avg. Two Year Performance

No purchase track record
11% Avg. Sale Return
6% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return4%1%14%28%11%
Sale Success Rate11 of 209 of 208 of 208 of 207 of 20
Drugs » Biotechnology

CEO, Director:

Holdings: 97.37K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 0.62K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--